Cargando…

Experimental models of metabolic and alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is a multi-systemic disease that is considered the hepatic manifestation of metabolic syndrome (MetS). Because alcohol consumption in NAFLD patients is common, there is a significant overlap in the pathogenesis of NAFLD and alcoholic liver disease (ALD). Ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buyco, Delfin Gerard, Martin, Jasmin, Jeon, Sookyoung, Hooks, Royce, Lin, Chelsea, Carr, Rotonya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789066/ https://www.ncbi.nlm.nih.gov/pubmed/33505147 http://dx.doi.org/10.3748/wjg.v27.i1.1

Ejemplares similares

Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation
por: Jeon, Sookyoung, et al.
Publicado: (2023)

Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism
por: Buyco, Delfin Gerard, et al.
Publicado: (2023)

Liver-specific ceramide reduction alleviates steatosis and insulin resistance in alcohol-fed mice
por: Correnti, Jason, et al.
Publicado: (2020)

Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis
por: Pickett-Blakely, Octavia, et al.
Publicado: (2018)

Embracing the principles of practice transfer to get the word out on the new metabolic dysfunction-associated steatotic liver disease nomenclature
por: Carr, Rotonya M.
Publicado: (2023)

Alcohol and Metabolic-associated Fatty Liver Disease
por: Sun, Fu-Rong, et al.
Publicado: (2021)

Absence of Perilipin 2 Prevents Hepatic Steatosis, Glucose Intolerance and Ceramide Accumulation in Alcohol-Fed Mice
por: Carr, Rotonya M., et al.
Publicado: (2014)

The Impact of Phytochemicals in Obesity-Related Metabolic Diseases: Focus on Ceramide Metabolism
por: Kim, Eunkyeong, et al.
Publicado: (2023)

Effects of DA-5513 on alcohol metabolism and alcoholic fatty liver in rats
por: Yu, Jae Young, et al.
Publicado: (2018)

Metabolic drivers of non-alcoholic fatty liver disease
por: Bence, Kendra K., et al.
Publicado: (2020)

Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development
por: Jin, Yujin, et al.
Publicado: (2023)

Problems and Challenges Associated with Renaming Non-alcoholic Fatty Liver Disease to Metabolic Associated Fatty Liver Disease
por: Zeng, Minghui, et al.
Publicado: (2023)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

New murine model of alcoholic hepatitis in obesity-induced metabolic-associated fatty liver disease
por: Cheng, Yuqing, et al.
Publicado: (2023)

Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline
por: Sung, Ki-Chul, et al.
Publicado: (2012)

Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease
por: Ore, Ayokanmi, et al.
Publicado: (2019)

In NAFLD, You Are What You Eat, Not Simply How Much You Eat
por: Carr, Rotonya M.
Publicado: (2017)

Nature or Nurture? The Answer Is “Both” in Nonalcoholic Steatohepatitis
por: Carr, Rotonya M.
Publicado: (2020)

DDS Profile: Rotonya M. Carr, MD, FACP
por: Carr, Rotonya M.
Publicado: (2022)

DDS Perspective: Time to Get Serious About the Global Pandemic
por: Carr, Rotonya M.
Publicado: (2022)

Metabolic profiling of adolescent non-alcoholic fatty liver disease
por: Hartley, April, et al.
Publicado: (2019)

Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease
por: El Hadi, Hamza, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant
por: Gitto, Stefano, et al.
Publicado: (2016)

Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
por: Kim, Tae Hyun, et al.
Publicado: (2021)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

Retraction Note: Effects of DA-5513 on alcohol metabolism and alcoholic fatty liver in rats
por: Yu, Jae Young, et al.
Publicado: (2020)

Association between metabolic syndrome and the development of non-alcoholic fatty liver disease
por: WANG, YI, et al.
Publicado: (2013)

Neonatal Orally Administered Zingerone Attenuates Alcohol-Induced Fatty Liver Disease in Experimental Rat Models
por: Asiedu, Bernice, et al.
Publicado: (2023)

A Quantitative Systems Pharmacology Model of Liver Lipid Metabolism for Investigation of Non-Alcoholic Fatty Liver Disease
por: Rieger, Theodore R., et al.
Publicado: (2022)

Hydrogen sulphide in liver glucose/lipid metabolism and non‐alcoholic fatty liver disease
por: Mateus, Inês, et al.
Publicado: (2021)

Alterations of Central Liver Metabolism of Pediatric Patients with Non-Alcoholic Fatty Liver Disease
por: Berndt, Nikolaus, et al.
Publicado: (2022)

Correlation of visfatin level with non-alcoholic fatty liver in metabolic syndrome
por: Mousavi, Zohreh, et al.
Publicado: (2017)

Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease
por: Shi, Dongmei, et al.
Publicado: (2019)

The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
por: Perla, Francesco M., et al.
Publicado: (2017)

Organismal Fructose Metabolism in Health and Non-Alcoholic Fatty Liver Disease
por: Skenderian, Shea, et al.
Publicado: (2020)

Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
por: Lefere, Sander, et al.
Publicado: (2019)

Underestimation of metabolic unhealthiness and overestimation of non-alcoholic fatty liver disease
por: Sarathi, Vijaya, et al.
Publicado: (2023)

Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review
por: Odriozola, Aitor, et al.
Publicado: (2023)

Establishment of the Tree Shrew as an Alcohol-Induced Fatty Liver Model for the Study of Alcoholic Liver Diseases
por: Xing, Huijie, et al.
Publicado: (2015)

Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease
por: Liao, Chia-Jung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ni5cde9l30bc628ioa2gjhlbsr